IR-MED Names Moshe Gerber as New CEO

ROSH PINNA, Israel--(BUSINESS WIRE)--IR-Med (“IR-MED or the “Company”) (OTCQB:IRME), an innovative development-stage medical device company utilizing Infra-Red light spectroscopy (IR) and Artificial Intelligence (AI) technologies to develop non-invasive detection devices, today announced the appointment of Moshe Ger...

Related Keywords

California ,United States ,San Jose State University ,United Kingdom ,Israel ,Oded Bashan ,Exchange Commission ,Vp Business Development ,Aviv University ,Artificial Intelligence ,Moshe Gerber ,Chief Executive Officer ,Gerium Medical ,Mennen Medical ,Computer Science ,Med Board ,Harbor Statement ,Private Securities Litigation Reform Act ,